Jeng‐Fu Yang

1.4k total citations
41 papers, 998 citations indexed

About

Jeng‐Fu Yang is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jeng‐Fu Yang has authored 41 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 32 papers in Hepatology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jeng‐Fu Yang's work include Liver Disease Diagnosis and Treatment (32 papers), Hepatitis C virus research (27 papers) and Hepatitis B Virus Studies (22 papers). Jeng‐Fu Yang is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Hepatitis C virus research (27 papers) and Hepatitis B Virus Studies (22 papers). Jeng‐Fu Yang collaborates with scholars based in Taiwan, Mongolia and Vietnam. Jeng‐Fu Yang's co-authors include Ming‐Lung Yu, Wan‐Long Chuang, Chia‐Yen Dai, Jee‐Fu Huang, Chung‐Feng Huang, Zu‐Yau Lin, Meng‐Hsuan Hsieh, Ming‐Yen Hsieh, Ming‐Lun Yeh and Shinn‐Cherng Chen and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Jeng‐Fu Yang

39 papers receiving 982 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeng‐Fu Yang Taiwan 17 813 685 160 78 76 41 998
Ching‐I Huang Taiwan 15 747 0.9× 659 1.0× 111 0.7× 81 1.0× 73 1.0× 87 956
Angeline Oi–Shan Lo Hong Kong 13 943 1.2× 730 1.1× 137 0.9× 75 1.0× 157 2.1× 22 1.2k
Osman Özdoğan Türkiye 16 803 1.0× 504 0.7× 168 1.1× 82 1.1× 235 3.1× 66 1.1k
Jesús Castillo Spain 13 522 0.6× 500 0.7× 130 0.8× 36 0.5× 103 1.4× 26 872
Kazuyuki Ohata Japan 9 538 0.7× 382 0.6× 103 0.6× 50 0.6× 121 1.6× 16 766
Karen Sennett United Kingdom 8 572 0.7× 405 0.6× 149 0.9× 89 1.1× 103 1.4× 14 896
Peter Eddowes United Kingdom 6 1.1k 1.3× 686 1.0× 302 1.9× 78 1.0× 195 2.6× 14 1.2k
Martine Walmsley United Kingdom 9 654 0.8× 564 0.8× 115 0.7× 82 1.1× 350 4.6× 25 1.0k
Cristiane Valle Tovo Brazil 17 516 0.6× 386 0.6× 76 0.5× 33 0.4× 72 0.9× 69 696
Leonardo de Lucca Schiavon Brazil 19 825 1.0× 753 1.1× 54 0.3× 41 0.5× 175 2.3× 99 1.2k

Countries citing papers authored by Jeng‐Fu Yang

Since Specialization
Citations

This map shows the geographic impact of Jeng‐Fu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeng‐Fu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeng‐Fu Yang more than expected).

Fields of papers citing papers by Jeng‐Fu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeng‐Fu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeng‐Fu Yang. The network helps show where Jeng‐Fu Yang may publish in the future.

Co-authorship network of co-authors of Jeng‐Fu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jeng‐Fu Yang. A scholar is included among the top collaborators of Jeng‐Fu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeng‐Fu Yang. Jeng‐Fu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Tyng‐Yuan, Yuting Zeng, Po‐Cheng Liang, et al.. (2025). Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues. Alimentary Pharmacology & Therapeutics. 61(9). 1458–1466.
2.
Jang, Tyng‐Yuan, Yong Zeng, Po‐Cheng Liang, et al.. (2024). Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues. Liver International. 45(4). e16149–e16149. 4 indexed citations
3.
Jang, Tyng‐Yuan, Po‐Cheng Liang, Yu‐Ju Wei, et al.. (2023). Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease. The Kaohsiung Journal of Medical Sciences. 40(3). 304–314. 10 indexed citations
4.
Huang, Jee‐Fu, Pei‐Chien Tsai, Ming‐Lun Yeh, et al.. (2023). Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 3 indexed citations
5.
Liang, Po‐Cheng, Pei‐Chien Tsai, Po‐Yao Hsu, et al.. (2023). A people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co–V2 pandemic. Journal of Microbiology Immunology and Infection. 56(3). 586–597. 5 indexed citations
6.
Tsai, Pei‐Chien, Chia‐Yen Dai, Ching‐I Huang, et al.. (2022). Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern Taiwan. The Kaohsiung Journal of Medical Sciences. 38(7). 694–702. 2 indexed citations
7.
Jang, Tyng‐Yuan, Yi‐Hung Lin, Po‐Cheng Liang, et al.. (2022). Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes. The Kaohsiung Journal of Medical Sciences. 38(9). 897–906. 4 indexed citations
8.
Tsai, Pei‐Chien, Ching‐I Huang, Ming‐Lun Yeh, et al.. (2021). Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan. BMJ Open. 11(3). e042861–e042861. 12 indexed citations
9.
Su, Shih‐Bin, Yi‐Yu Chen, Ching‐I Huang, et al.. (2016). Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol. Journal of clinical lipidology. 10(2). 420–425.e1. 81 indexed citations
10.
Yang, Jeng‐Fu, Chung‐Feng Huang, Po‐Yen Lee, et al.. (2016). Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core protein. The Kaohsiung Journal of Medical Sciences. 32(10). 487–493. 2 indexed citations
11.
Hsieh, Meng‐Hsuan, Ming‐Yen Hsieh, Chung‐Feng Huang, et al.. (2016). Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan. The Kaohsiung Journal of Medical Sciences. 32(10). 526–530. 7 indexed citations
12.
Hsieh, Meng‐Hsuan, Ming‐Yen Hsieh, Chung‐Feng Huang, et al.. (2016). Anti‐HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan. The Kaohsiung Journal of Medical Sciences. 32(2). 96–102. 4 indexed citations
13.
Huang, Chung‐Feng, Ming‐Lun Yeh, Pei‐Chien Tsai, et al.. (2014). Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication. Journal of Hepatology. 61(1). 67–74. 94 indexed citations
14.
Huang, Shih‐Hui, I‐Chen Wu, Deng‐Chyang Wu, et al.. (2012). Occupational risks of esophageal cancer in Taiwanese men. The Kaohsiung Journal of Medical Sciences. 28(12). 654–659. 13 indexed citations
15.
Chen, Chun‐Hao, Jee‐Fu Huang, Chung‐Feng Huang, et al.. (2012). Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy. Hepatology International. 7(1). 162–170. 4 indexed citations
16.
Yang, Jeng‐Fu, Jee‐Fu Huang, Chia‐Yen Dai, et al.. (2010). Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community‐based Study. The Kaohsiung Journal of Medical Sciences. 26(9). 461–469. 91 indexed citations
17.
Yang, Jeng‐Fu, Chia‐Yen Dai, Jee‐Fu Huang, et al.. (2009). Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice. Alimentary Pharmacology & Therapeutics. 29(9). 1000–1010. 17 indexed citations
18.
Huang, Jee‐Fu, Wan‐Long Chuang, Ming‐Lung Yu, et al.. (2009). Hepatitis C Virus Infection And Metabolic Syndrome—A Community‐Based Study in an Endemic Area of Taiwan. The Kaohsiung Journal of Medical Sciences. 25(6). 299–305. 36 indexed citations
19.
Huang, Chung‐Feng, Jeng‐Fu Yang, Jee‐Fu Huang, et al.. (2009). Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response. Journal of Gastroenterology and Hepatology. 25(4). 758–765. 22 indexed citations
20.
Yang, Jeng‐Fu, Chia‐Yen Dai, Wan‐Long Chuang, et al.. (2006). Prevalence and Clinical Significance of HGV/GBV-C Infection in Patients with Chronic Hepatitis B or C. Japanese Journal of Infectious Diseases. 59(1). 25–30. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026